Chronic Myeloid Leukemia

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Hematology
Cover of the book Chronic Myeloid Leukemia by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319331980
Publisher: Springer International Publishing Publication: August 17, 2016
Imprint: Springer Language: English
Author:
ISBN: 9783319331980
Publisher: Springer International Publishing
Publication: August 17, 2016
Imprint: Springer
Language: English

This book provides state-of-the-art reviews of key issues and recent developments relating to chronic myeloid leukemia (CML), acquainting the reader with advances in research, treatment, and promotion of public health. Among the management topics addressed are the choices, advantages, and pitfalls of first-, second-, and third-line treatments; the European LeukemiaNet recommendations; management of adverse effects of tyrosine kinase inhibitors (TKI); management of CML blast crisis; management of pregnancy in the context of CML; the role of hematopoietic cell transplantation; the current experience with TKI discontinuation; and the value of interferon α in improving the outcome of TKI treatment. Various aspects of relevance to treatment outcome are discussed, including prognostic scores, molecular monitoring (principles and interlaboratory standardization), and response-related predictors of survival. Furthermore, updates are provided on the increasing prevalence of CML and its implications and on the changing cost of care for CML, taking into account the forthcoming impact of availability of generic imatinib. 

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book provides state-of-the-art reviews of key issues and recent developments relating to chronic myeloid leukemia (CML), acquainting the reader with advances in research, treatment, and promotion of public health. Among the management topics addressed are the choices, advantages, and pitfalls of first-, second-, and third-line treatments; the European LeukemiaNet recommendations; management of adverse effects of tyrosine kinase inhibitors (TKI); management of CML blast crisis; management of pregnancy in the context of CML; the role of hematopoietic cell transplantation; the current experience with TKI discontinuation; and the value of interferon α in improving the outcome of TKI treatment. Various aspects of relevance to treatment outcome are discussed, including prognostic scores, molecular monitoring (principles and interlaboratory standardization), and response-related predictors of survival. Furthermore, updates are provided on the increasing prevalence of CML and its implications and on the changing cost of care for CML, taking into account the forthcoming impact of availability of generic imatinib. 

More books from Springer International Publishing

Cover of the book Embodied Curriculum Theory and Research in Arts Education by
Cover of the book Balanced and Cyclical Growth in Models of Decentralized Economy by
Cover of the book Medical Sociology in Africa by
Cover of the book Gravitational Wave Astrophysics with Pulsar Timing Arrays by
Cover of the book Development and Sustainable Growth of Mauritius by
Cover of the book Spectral Methods for Non-Standard Eigenvalue Problems by
Cover of the book Human Fetal Growth and Development by
Cover of the book Introduction to Parallel Computing by
Cover of the book The British Role in Iranian Domestic Politics (1951-1953) by
Cover of the book The Quantum Handshake by
Cover of the book Pronouns in Embedded Contexts at the Syntax-Semantics Interface by
Cover of the book Advanced Microsystems for Automotive Applications 2017 by
Cover of the book The Diabetic Foot by
Cover of the book Microbes in Food and Health by
Cover of the book Polynomial Chaos Methods for Hyperbolic Partial Differential Equations by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy